Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in KALA — KALA BIO, Inc.

CIK 1214717 BOSTON, MA
Back to KALA Full portfolio

Position in KALA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$251,112
+$205,950 QoQ
Shares Held
145,152
+2680.2% QoQ
Ownership
0.751%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 15 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KALA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,296,497 across 521 Biotechnology names. KALA ranks #390 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in KALA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $251,112 145,152
2026-03-31 $45,162 261,061
2025-12-31 $34,005 61,161
2025-09-30 $103,905 67,912
2025-06-30 $268,306 56,367
2025-03-31 $314,192 54,833
2024-12-31 $330,634 47,642
2024-09-30 $211,560 37,116
2024-06-30 $133,936 18,891
2024-03-31 $144,679 18,153
2023-12-31 $129,255 18,465
2023-09-30 $164,338 18,465
2023-06-30 $259,191 17,765
2022-12-31 $340,908 8,936
2022-09-30 $98,937 447,683
2022-06-30 $134,304 447,683
2022-03-31 $1,317,586 954,773
2021-12-31 $985,828 814,734
2021-09-30 $2,445,094 933,242
2021-06-30 $3,992,479 753,298
2021-03-31 $4,599,975 682,489
2020-12-31 $4,079,715 601,728
2020-09-30 $4,372,927 583,057
2020-06-30 $6,617,779 629,665
2020-03-31 $3,030,185 344,731